Greater Cannabis Company (GCAN) Cash & Equivalents Growth (1y) (2018 - 2026)
Greater Cannabis Company (GCAN) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | -39.02% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 120.45% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 12.78% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 50.32% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -32.64% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 138.97% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 37.30% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -12.11% |
| 10 | Greater Cannabis Company | 236,233.75 | 234,794.75 | - | -96.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.89% |
| Dec 31, 2025 | -98.58% |
| Sep 30, 2025 | -65.71% |
| Jun 30, 2025 | -66.74% |
| Mar 31, 2025 | -64.27% |
| Dec 31, 2024 | -65.62% |
| Jun 30, 2024 | -66.64% |
| Dec 31, 2023 | -38.21% |
| Jun 30, 2023 | -22.64% |
| Dec 31, 2022 | -28.47% |
| Jun 30, 2022 | -41.16% |
| Dec 31, 2021 | 234.23% |
| Sep 30, 2021 | 155.47% |
| Jun 30, 2021 | 131.46% |
| Mar 31, 2021 | 7.25% |
| Dec 31, 2020 | 358.00% |
| Sep 30, 2020 | 289.62% |
| Jun 30, 2020 | 181.99% |
| Mar 31, 2020 | 79.06% |
| Dec 31, 2019 | -58.82% |